BUSINESS WIRE)--Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Our recently announced acquisition of Cognigen, Inc. of Buffalo, NY, which closed on September 2, 2014, will add top-quality clinical trial data analysis to our offerings, and will more than double our staff from 30 to 65, add nearly 50% to revenues, and add to earnings in the coming fiscal year that begins September 1.
Hey, check out all the research scientist jobs. Post your resume today!
